SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-192554
Filing Date
2014-05-09
Accepted
2014-05-09 16:31:45
Documents
11
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d699188d10q.htm 10-Q 394919
2 EX-10.4 d699188dex104.htm EX-10.4 70183
3 EX-31.1 d699188dex311.htm EX-31.1 9640
4 EX-31.2 d699188dex312.htm EX-31.2 9865
5 EX-32.1 d699188dex321.htm EX-32.1 5166
  Complete submission text file 0001193125-14-192554.txt   4600273

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT aria-20140331.xml EX-101.INS 530532
7 XBRL TAXONOMY EXTENSION SCHEMA aria-20140331.xsd EX-101.SCH 50798
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aria-20140331_cal.xml EX-101.CAL 70507
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aria-20140331_def.xml EX-101.DEF 306995
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE aria-20140331_lab.xml EX-101.LAB 393832
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aria-20140331_pre.xml EX-101.PRE 368890
Mailing Address 26 LANDSDOWNE CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE ST CAMBRIDGE MA 02139 6174940400
ARIAD PHARMACEUTICALS INC (Filer) CIK: 0000884731 (see all company filings)

IRS No.: 223106987 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36172 | Film No.: 14829621
SIC: 2836 Biological Products, (No Diagnostic Substances)